Valentyna Starodub
I have long experience in the Pharmaceutical industry. In my previous jobs both in the Netherlands and Ireland, with world-wide leading pharmaceutical companies, I led teams of Regulatory professionals. I hold a Ph.D. in biotechnology and have a broad experience in regulatory CMC. I am fluent in English, Dutch, Ukrainian and Russian. My specialism is strategic decision making for large projects. The most what I appreciate in the STARoDub team is knowledge, professionalism and the team effort.
Approaches to include drug substance quality information in a drug product application (June 2022)
Author: Valentyna Starodub
How to select a cell line to produce a biosimilar (June 2021)
Author: Valentyna Starodub
News on the Postponement of the EU Medical Device Regulation, Corrigenda and MDCG guidance (June 2020)
Author: Valentyna Starodub
EU MDR impact on importers and distributors (March 2020)
Author: Valentyna Starodub
Radiopharmaceuticals – How to Register in EU? (October 2019)
Author: Valentyna Starodub
Is your Active Pharmaceutical Ingredient quality control strategy up to standard? (July 2019)
Author: Valentyna Starodub
What is new under the EU MDR for software manufacturers? (December 2018)
Author: Valentyna Starodub